Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Neurology·2026
Same author

Optimizing rare neurological disease trials: Bayesian frameworks and hierarchical models for improved efficiency in clinical trial design.

Journal of biopharmaceutical statistics·2026
Same author

A Phase 3 Trial of Brepocitinib in Dermatomyositis.

The New England journal of medicine·2026
Same author

Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease.

Therapeutic advances in rare disease·2026
Same author

Shared governance of international myositis networks.

Clinical and experimental rheumatology·2026
Same author

Dynamics of Nerve Conduction Studies in Patients With Guillain-Barré Syndrome.

Muscle & nerve·2026
Same journal

Preface.

Frontiers of neurology and neuroscience·2021
Same journal

Hypocretin/Orexin, Sleep and Alzheimer's Disease.

Frontiers of neurology and neuroscience·2021
Same journal

Sleep and Metabolism: Implication of Lateral Hypothalamic Neurons.

Frontiers of neurology and neuroscience·2021
Same journal

The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System.

Frontiers of neurology and neuroscience·2021
Same journal

Heterogeneity of Hypocretin/Orexin Neurons.

Frontiers of neurology and neuroscience·2021
Same journal

Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.

Frontiers of neurology and neuroscience·2021
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

Idiopathic inflammatory myopathies.

Mazen M Dimachkie, Richard J Barohn

    Frontiers of Neurology and Neuroscience
    |April 8, 2009
    PubMed
    Summary
    This summary is machine-generated.

    The myositis landscape has evolved, distinguishing inflammatory myopathies like polymyositis and dermatomyositis from inclusion body myositis (IBM) and necrotizing myopathy. Understanding these subtypes is crucial for effective treatment approaches.

    Related Experiment Videos

    Last Updated: Jun 24, 2026

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
    10:55

    Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

    Published on: October 31, 2025

    Area of Science:

    • Neurology
    • Immunology
    • Pathology

    Background:

    • Myositis classification has evolved since dermatomyositis was first described over a century ago.
    • Diagnostic criteria for polymyositis and dermatomyositis were established in 1975.
    • Distinct pathological features and clinical presentations differentiate various myositis subtypes.

    Purpose of the Study:

    • To review the evolution of myositis classification and understanding.
    • To highlight the distinct characteristics of inclusion body myositis (IBM) and necrotizing myopathy.
    • To discuss the implications for diagnosis and treatment of inflammatory myopathies.

    Main Methods:

    • Historical review of myositis research and classification.
    • Comparison of clinical and pathological features of different myositis subtypes.
    • Analysis of treatment responses based on myositis classification.

    Main Results:

    • Polymyositis and dermatomyositis are generally responsive to immunosuppressive therapy.
    • Inclusion body myositis (IBM) is clinically and pathologically distinct, characterized by proximal and distal weakness, and is refractory to standard therapies.
    • Necrotizing myopathy, a recently described subtype, shows necrotic fibers and may require aggressive immunosuppressive treatment.

    Conclusions:

    • Myositis classification has advanced, recognizing distinct entities like IBM and necrotizing myopathy.
    • Accurate diagnosis based on clinical and pathological features is essential for tailoring treatment strategies.
    • Further research into the pathogenesis and optimal management of refractory myositis subtypes is warranted.